New technology and news

Good Article Sharing

CDE Releases Annual Report on Clinical Trial Progress of New Drug Registration in China (2021)

CDE Releases Annual Report on Clinical Trial Progress of New Drug Registration in China (2021)

On June 7, 2022, CDE released the Annual Report on the Progress of Clinical Trials for New Drug Registration in China (2021). Based on the registration information of the drug clinical trial registration and information disclosure platform, the report comprehensively summarizes and analyzes the status quo of new drug registration clinical trials in China in 2021, and compares and analyzes the changing trend characteristics in the past three years.

2023-02-02

Changrui Biotech held the groundbreaking ceremony and the awarding ceremony of the three bases

Changrui Biotech held the groundbreaking ceremony and the awarding ceremony of the three bases

On July 18, 2022, the groundbreaking ceremony of the first phase of CDMO laboratory construction and the unveiling ceremony of the three major bases of Changrui Biotechnology (Chengdu) Co., Ltd. (hereinafter referred to as "Changrui Biotechnology") were held in Chengdu Tianfu International Biocity.

2023-02-02

The first publicity of the vehicle drug development and macromolecule biodrug R&D and pilot scale-up service platform project

The first publicity of the vehicle drug development and macromolecule biodrug R&D and pilot scale-up service platform project

Changrui Biotechnology (Chengdu) Co., Ltd. entrusted Chengdu Green Island Enterprise Management Co., Ltd. to undertake the preparation of the environmental impact report of the carrier drug development and macromolecule biodrug R&D and pilot scale-up service platform project, and according to the Measures for Public Participation in Environmental Impact Assessment (Order No. 4 of the Ministry of Ecology and Environment), the relevant information of the project is hereby published as follows:

2023-02-02

Warm congratulations to the company on the joy of housewarming - a new starting point for building dreams

Warm congratulations to the company on the joy of housewarming - a new starting point for building dreams

October 24, 2022 is a memorable day in the development history of Changrui Biotechnology, and all employees congratulated the housewarming at the new site of the company, Chengdu Tianfu International Biocity Area C Office Building.

2023-02-02

< 12 > proceed page

Macromolecular Biopharmaceutical Research*

2023-02-02

Changrui Biologics - a public technical service platform for vector drug development and macromolecular biopharmaceutical research

2023-02-02

Changrui Biotech participated in the 2022 college campus job fair

2023-02-02

Changrui Biotech participated in the signing ceremony of Chengdu Tianfu International Biocity with a total investment of more than 11 billion yuan - 2022 circle building strong chain project

2023-02-02

2021 Annual Drug Evaluation Report Released - These issues are worth paying attention to

2023-02-02

CDE issued three guiding principles, including the Technical Guidelines for Pharmaceutical Research and Evaluation of In Vivo Gene Therapy Products (Trial).

2023-02-02